array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(29) "Regeneron Pharmaceuticals Inc"
["slug"]=>
string(38) "c469a-us-regeneron-pharmaceuticals-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/b5187988-884a-43b7-980d-e1555548ab77"
["description"]=>
string(868) "At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in.
Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media.
An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. "
["address_street"]=>
string(25) "777 Old Saw Mill River Rd"
["address_place"]=>
string(9) "Tarrytown"
["address_region"]=>
string(8) "New York"
["founding_date"]=>
string(10) "1988-02-08"
["website_domain"]=>
string(13) "regeneron.com"
["website_url"]=>
string(25) "https://www.regeneron.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(10368)
["article_count"]=>
int(2433)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(130) "Jacob Gross: Finalist in the Prestigious Regeneron Science Talent Search Competition for COVID-19 Antibody Research - News Purpose"
["snippet_en"]=>
string(155) "Allyson Weseley, a science teacher at Roslyn High School, has nurtured the talents of Jacob Gross, a senior student who has been selected as a finalist for"
["url"]=>
string(139) "https://newspurpose.com/jacob-gross-finalist-in-the-prestigious-regeneron-science-talent-search-competition-for-covid-19-antibody-research/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6f97189a-ec03-472b-9156-8d05ffc1491d"
["source"]=>
string(15) "newspurpose.com"
["publication_date"]=>
string(10) "2024-03-07"
["categories"]=>
array(3) {
[0]=>
string(17) "Academic Research"
[1]=>
string(8) "Epidemic"
[2]=>
string(5) "Award"
}
}
[1]=>
array(7) {
["title_en"]=>
string(61) "Monoclonal antibodies: a new treatment to counter long COVID?"
["snippet_en"]=>
string(130) "A new small study reveals that a treatment used to treat acute infection caused by Covid-19 was also effective against long Covid."
["url"]=>
string(49) "https://francais.medscape.com/voirarticle/3610921"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/66dde446-8668-4abe-b158-b56fe6268b72"
["source"]=>
string(12) "medscape.com"
["publication_date"]=>
string(10) "2023-12-29"
["categories"]=>
array(1) {
[0]=>
string(8) "Epidemic"
}
}
[2]=>
array(7) {
["title_en"]=>
string(95) "Sanders advocates for equity in pandemic response, presses for fair pricing in WHO treaty talks"
["snippet_en"]=>
string(95) "As the World Health Organization( WHO) members convene to forge a blueprint for future pandemic"
["url"]=>
string(137) "https://www.nationofchange.org/2023/11/08/sanders-advocates-for-equity-in-pandemic-response-presses-for-fair-pricing-in-who-treaty-talks/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/605009e0-11a1-4b50-8bb1-190ab95b16a1"
["source"]=>
string(18) "nationofchange.org"
["publication_date"]=>
string(10) "2023-11-08"
["categories"]=>
array(2) {
[0]=>
string(11) "US Politics"
[1]=>
string(8) "Epidemic"
}
}
[3]=>
array(7) {
["title_en"]=>
string(84) "NIH director hearing highlights science’s politicization in wake of COVID pandemic"
["snippet_en"]=>
string(145) "Monica Bertagnolli, nominee for the biomedical agency’s top job, fields questions from US senators about how she will rebuild trust in science."
["url"]=>
string(50) "https://www.nature.com/articles/d41586-023-03263-4"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/129b5e9c-919c-4f8c-9a91-f868000b672d"
["source"]=>
string(10) "nature.com"
["publication_date"]=>
string(10) "2023-10-19"
["categories"]=>
array(1) {
[0]=>
string(8) "Epidemic"
}
}
[4]=>
array(7) {
["title_en"]=>
string(64) "Regeneron Concession Narrows Covid Antibody-Cocktail Patent Suit"
["snippet_en"]=>
string(297) "Regeneron Pharmaceuticals Inc. agreed that its Covid-19 “antibody cocktail” was developed using technology that, unless it’s found to be shielded from liability under a legal “safe harbor,” would infringe a California biotechnology company’s valid patent, in a deal narrowing the case."
["url"]=>
string(101) "https://news.bloomberglaw.com/ip-law/regeneron-concession-narrows-covid-antibody-cocktail-patent-suit"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1f16816e-6a27-4622-9297-4857e7873aee"
["source"]=>
string(16) "bloomberglaw.com"
["publication_date"]=>
string(10) "2023-09-19"
["categories"]=>
array(5) {
[0]=>
string(5) "Legal"
[1]=>
string(26) "Product Quality and safety"
[2]=>
string(5) "R & D"
[3]=>
string(8) "Epidemic"
[4]=>
string(27) "Business Model & Innovation"
}
}
[5]=>
array(7) {
["title_en"]=>
string(101) "Regeneron to sell COVID-19 prophylactic antibody at internationally comparable price By Investing.com"
["snippet_en"]=>
string(84) "Regeneron to sell COVID-19 prophylactic antibody at internationally comparable price"
["url"]=>
string(143) "https://ph.investing.com/news/stock-market-news/regeneron-to-sell-covid19-prophylactic-antibody-at-internationally-comparable-price-93CH-983575"
["image_url"]=>
NULL
["source"]=>
string(13) "investing.com"
["publication_date"]=>
string(10) "2023-09-14"
["categories"]=>
array(2) {
[0]=>
string(21) "Competitive Behaviour"
[1]=>
string(8) "Epidemic"
}
}
[6]=>
array(7) {
["title_en"]=>
string(129) "Pharmalittle: White House imposes price limits for Regeneron Covid drug; lawmakers push federal agencies to prevent patent abuses"
["snippet_en"]=>
string(128) "A HHS deal for a Regeneron drug marks the first time the administration has directly used its leverage to challenge list prices."
["url"]=>
string(144) "https://www.statnews.com/pharmalot/2023/09/14/fda-patents-ftc-regeneron-covid19-medicare-alnylam-abbott-insulin-cepheid-danaher-tb-tuberculosis/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6bf5bb64-e8d8-4a07-8cc8-f0dfb3d89d62"
["source"]=>
string(12) "statnews.com"
["publication_date"]=>
string(10) "2023-09-14"
["categories"]=>
array(2) {
[0]=>
string(21) "Competitive Behaviour"
[1]=>
string(8) "Epidemic"
}
}
[7]=>
array(7) {
["title_en"]=>
string(108) "Signal- HHS/Regeneron Covid-19 deal includes list price clause for affordability - Pharmaceutical Technology"
["snippet_en"]=>
string(99) "Regeneron is developing an antibody for Covid-19 prevention with the help of US government funding."
["url"]=>
string(127) "https://www.pharmaceutical-technology.com/news/signal-hhs-regeneron-covid-19-deal-includes-list-price-clause-for-affordability/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5979cd7a-eb11-4458-be76-63f80c4a3721"
["source"]=>
string(29) "pharmaceutical-technology.com"
["publication_date"]=>
string(10) "2023-09-12"
["categories"]=>
array(2) {
[0]=>
string(21) "Competitive Behaviour"
[1]=>
string(8) "Epidemic"
}
}
[8]=>
array(7) {
["title_en"]=>
string(49) "Sanders to hold NIH director confirmation hearing"
["snippet_en"]=>
string(158) "An agreement by Regeneron on international pricing of a next-generation COVID-19 mAb that it is developing with U.S. government funding has paved the way f..."
["url"]=>
string(91) "https://www.biocentury.com/article/649197/sanders-to-hold-nih-director-confirmation-hearing"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/ea631a1c-cb56-462d-8682-c6b934f598bf"
["source"]=>
string(14) "biocentury.com"
["publication_date"]=>
string(10) "2023-09-11"
["categories"]=>
array(1) {
[0]=>
string(8) "Epidemic"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(197)
}
[1]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(193)
}
[2]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(152)
}
[3]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(99)
}
[4]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(95)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(83)
}
[6]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(70)
}
[7]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(61)
}
[8]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(51)
}
[9]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(50)
}
[10]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(46)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(44)
}
[12]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(35)
}
[13]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(35)
}
[14]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(34)
}
[15]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(33)
}
[16]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(33)
}
[17]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(32)
}
[18]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(31)
}
[19]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(31)
}
[20]=>
array(2) {
["name"]=>
string(14) "Product Review"
["count"]=>
int(31)
}
[21]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(29)
}
[22]=>
array(2) {
["name"]=>
string(8) "Verdicts"
["count"]=>
int(29)
}
[23]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(28)
}
[24]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(27)
}
[25]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(26)
}
[26]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(24)
}
[27]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(23)
}
[28]=>
array(2) {
["name"]=>
string(11) "Sponsorship"
["count"]=>
int(20)
}
[29]=>
array(2) {
["name"]=>
string(8) "Politics"
["count"]=>
int(20)
}
}
}
c469a-us-regeneron-pharmaceuticals-inc
Regeneron Pharmaceuticals Inc
Location
New York
Founded
1988-02-08
Website
https://www.regeneron.com
Articles
2433 Articles
Category
Pharmaceutical Preparations
Description
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in.
Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media.
An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
Allyson Weseley, a science teacher at Roslyn High School, has nurtured the talents of Jacob Gross, a senior student who has been selected as a finalist for
Regeneron Pharmaceuticals Inc. agreed that its Covid-19 “antibody cocktail” was developed using technology that, unless it’s found to be shielded from liability under a legal “safe harbor,” would infringe a California biotechnology company’s valid patent, in a deal narrowing the case.
An agreement by Regeneron on international pricing of a next-generation COVID-19 mAb that it is developing with U.S. government funding has paved the way f...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
